13Jun/23

Br J Pharmacol: Complement C3 as a New Target for Reducing Proteinuria in Patients with Hypertensive Nephropathy

The increasing number of clinical diseases involving pathological contributions of the complement system has prompted renewed interest in therapeutic options to modulate this host defense pathway. Based on these findings, the pharmaceuticalRead More…